Stereotaxis, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

AMEX
Lagoda Investment Management, L.P. has filed a Schedule 13G, reporting a 5.1% beneficial ownership stake in medical technology company Stereotaxis, Inc. as of March 31, 2025.